Contract manufacturer Ritedose and its 400 employees will be joining the Novo Nordisk group, after Novo Holdings acquired the firm from AGIC Capital and Humanwell, a Novo press release reports.
The price of the acquisition has not been revealed, but in April, business media Bloomberg reported that the funds were looking for a minimum payment of USD 1.5bn.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.